Primaegis Research · Investment Analysis Pipeline

Chembond Chemicals Ltd

NSE: CHEMBONDCH  |  BSE: 544450  |  Small-cap  |  Specialty Chemicals — Water Technologies
Debt-free balance sheet Water tech ~87% of revenue Q4FY26 PAT +33% YoY Rising working-capital days Low cash conversion (CFO/PAT ~0.23) Post-demerger pure-play Report: 16 Jun 2026
₹180.0
▲ +5.0%
Mkt Cap ₹484 Cr
52W: ₹104.85 – ₹245.0
16 Jun 2026
Market Cap
₹484 Cr
Small-cap
CMP
₹180
+5.0% today
ROCE (cons.)
~24%
FY26
ROE (cons.)
~18%
FY26
P/E (cons.)
13.9x
vs median 12.1x
Revenue TTM
₹326 Cr
FY26, +12% YoY
PAT TTM
₹35 Cr
FY26, +12.5%
Debt / Equity
~0.0
Debt-free
Promoter
~65%
Free float ~35%
EV/EBITDA
8.5x
Source: TradingView
Material Events & Latest Filings
DateEventDetailRead
16 May 2026FY26 audited results + concallConsol. revenue ₹326.15 Cr (+12%), EBITDA ₹51 Cr (+7%), PBT ₹45 Cr (+7%), PAT ₹34.78 Cr (+12.5%). Final dividend ₹1.25/sh.Positive
Q4 FY26Nine-quarter high revenueQ4 revenue ₹101.4 Cr (+30% YoY); Q4 PAT +33% YoY. Water-treatment chemicals +~10% volume YoY tracking sector recovery.Positive
07 Apr 2025NCLT-approved demerger completedComposite scheme: water technologies + construction chemicals + cleaning & hygiene + distribution housed in this entity (CHEMBONDCH). Metal-treatment/coatings/adhesives/biotech moved to Chembond Material Technologies.Structural
FY26Order book commentaryWater Technologies (~87% of revenue) grew ~5% in FY26 supported by a strong order book; management pursuing expansion in construction chemicals and distribution.Watch
Till 23 Jan 2027Promoter lock-inPost-relisting promoter minimum lock-in runs ~18 months (per TradingView corporate-action panel).Neutral

Sources: company FY26 results & investor communication (May 2026), demerger scheme documents, market-data aggregators. Verify against BSE/NSE primary filings.

A1 · Business Model

Chembond Chemicals Ltd (incorporated 1974, HQ Navi Mumbai) is a specialty-chemicals group. Following the composite scheme of arrangement that completed with NCLT approval in April 2025, the present listed entity (NSE: CHEMBONDCH) is a re-focused vehicle housing four businesses: Water Technologies, Construction Chemicals, Cleaning & Hygiene, and a Distribution arm. The legacy metal-treatment chemicals, coatings, industrial adhesives, sealants and biotech operations were carved into a separate listed company (Chembond Material Technologies). This makes CHEMBONDCH largely a water-treatment specialty-chemicals play — the water vertical contributes roughly 87% of consolidated revenue.

The water business supplies chemicals, dosing systems and services for industrial water treatment and reuse — covering raw, cooling, boiler, produced and waste water — with recent product launches including Kem Watreat® kits and the upgraded Chembond FLUX® monitor. It is a recurring-consumption, application-engineering model serving refineries, petrochemicals, fertilizers, power and general industry.

History & Evolution
1974 · Founded
Specialty chemicals platform
Multi-vertical group (water, metal, construction, adhesives)
Dec 2023 · Demerger announced
Apr 2025 · Re-focused water-tech pure-play ★

Why now: the demerger gives investors a cleaner, asset-light, debt-free water-treatment franchise riding India’s industrial water reuse / zero-liquid-discharge tailwind, with FY26 marking the first full year of the re-shaped business and a nine-quarter revenue high in Q4.

Value Chain Position
Chemical raw materials
Formulation & blending
Chembond ★ (chemicals + dosing systems + service)
Industrial plants (refining, fertilizer, power)
Treated / reused water
Revenue Mix (FY26, approximate)
SegmentShare of RevenueCharacter
Water Technologies (chemicals + equipment + service)~87%Recurring consumables + project/tender equipment
Construction Chemicals~ low double digitGrowth focus; cyclical to construction activity
Cleaning & Hygiene + DistributionBalanceDistribution-led, lower margin

Segment split is approximate, derived from management commentary; exact segmental disclosure should be verified in the FY26 annual report.

Moat Assessment (qualitative — not a guarantee of future performance)

Switching cost

Water-treatment programs are embedded in customer plant operations with on-site service — Moderate.

Intangibles / IP

Proprietary formulations & monitoring kits (Kem Watreat, FLUX) — Moderate.

Efficient scale

Sub-₹500 Cr cap competing with far larger Wabag/Ion Exchange — Weak/niche.

R&D & Pipeline

Application-engineering led R&D; recent commercialised products include Kem Watreat® modular test kits and an upgraded Chembond FLUX® online monitor. Exact R&D spend as % of sales is not separately disclosed post-demerger. Pipeline data not fully disclosed — monitor earnings calls and the FY26 annual report.

A2 · Capabilities + Strategy

Manufacturing

Multiple specialty-chemical blending sites; asset-light model (fixed assets only ~₹23 Cr against ₹326 Cr revenue).

Service network

On-site water-treatment service teams — the recurring, sticky part of the model.

Distribution

Dedicated distribution arm broadening reach across industrial customers.

Strategic Priorities

Scale water tech

Deepen recurring chemicals consumption + win equipment/tender orders.

Grow construction chemicals

Identified expansion vertical to diversify beyond water.

Asset-light, debt-free growth

Fund expansion from internal accruals; preserve zero-debt balance sheet.

A3 · Opportunity — Why & Timeframe

India’s industrial water-treatment and reuse market is structurally expanding, driven by tightening discharge norms (Zero Liquid Discharge mandates), water scarcity in industrial clusters, and rising reuse/recycle adoption across refining, fertilizer, power and chemicals. As a chemicals-and-service supplier, Chembond participates in the recurring-consumption layer of this theme rather than the lumpy EPC layer.

Near-term (0–12M)

Volume recovery in water-treatment chemicals (+~10% Q4); margin holding ~15%.

Medium-term (1–3Y)

Construction-chemicals scale-up + distribution leverage; first full multi-year record as a pure-play.

Long-term (3Y+)

Structural ZLD/reuse adoption; potential to close the valuation gap to larger water peers if growth sustains.

A4 · Operations + Projects

The business is asset-light: net block ~₹23 Cr, no meaningful CWIP, and zero borrowings. Growth is being funded internally. Q4 FY26 revenue of ₹101.4 Cr was the highest in nine quarters, with management attributing momentum to a broad water-sector recovery and a healthy order book in the water vertical.

Operational itemFY26 readSignal
Capacity modelAsset-light blending + service; low fixed-asset intensityCapital-efficient
Order book (water)Described as “strong”; supported ~5% water growthMonitor
CapexNo large announced capex; FCF ~₹1 Cr FY26Neutral
A5 · Financials + Growth (5-Year)

Consolidated figures, ₹ Cr. FY24 onward reflect the re-shaped continuing business (post-demerger restatement) — the FY22→FY23→FY24 revenue step-down is a structural carve-out, not a demand collapse. Margins expanded sharply once the lower-margin demerged lines were removed.

FYRevenueEBITDAOPM%PATPAT margin
FY22349175%144.0%
FY23440358%255.7%
FY24*2834215%3010.6%
FY252924214%3110.6%
FY263264715%3510.7%

*FY24/FY25 reflect continuing operations post carve-out. EPS FY26 ₹13.0 (face value ₹5).

A6 · Regulatory Changes + Impact
DriverMechanismDirection
Zero Liquid Discharge (ZLD) normsCPCB/SPCB tightening pushes industrial water reuse & chemical demandPositive
Industrial water-reuse mandatesRefineries/fertilizer/power compelled to recycle — recurring chemicals demandPositive
Input (crude-derivative) cost & import dutiesSpecialty-chemical feedstock price swings affect gross marginNeutral / variable
Environmental compliance costsHigher compliance overhead for manufacturing sitesNeutral

No company-specific PLI scheme identified. Sector tailwind is regulation-led water reuse rather than a direct subsidy.

A7 · Research Reports & Data Mix

Institutional sell-side coverage of CHEMBONDCH is thin given the sub-₹500 Cr market cap and recent relisting. Available data is largely from market-data aggregators and company disclosures rather than broad brokerage consensus.

Estimate (TradingView panel)Jun-26Sep-26
EPS growth (est.)+87%+62%
Sales growth (est.)+55%+39%

Source: TradingView estimate panel — research framing only, not a recommendation. These are model estimates against a low prior-year base; treat as directional, not firm guidance. Verify against any formal broker notes.

A8 · Balance Sheet + Cash Flow + Fraud Filter
Item (₹ Cr)FY26FY25FY24
Equity capital131313
Reserves194161130
Borrowings000
Fixed assets232122
Investments303527
Other assets (incl. WC)200157131
Total assets254214180
Cash Flow
₹ CrFY26FY25FY24
CFO810-56
FCF15-75
CFO/OP47%50%-105%
Fraud Filter
⚠️ Receivable days rising: 99 (FY24) → 125 → 128 (FY26)
⚠️ Working-capital days 104 → 154; CCC ~110 days
🔴 CFO/PAT weak: ~₹8 Cr CFO vs ₹35 Cr PAT (~0.23x) FY26
✅ Debt-free; no borrowings
✅ Inventory days stable (~49–53)
✅ Promoter pledge: none flagged

The big FY24 negative CFO is a demerger-year distortion. The persistent gap between PAT and operating cash — driven by rising debtor and working-capital days — is the single most important quality watch-item.

A9 · P&L Deep Dive — Quarterly
QuarterRevenueQoQYoYEBITDAOPM%PATEPS
Mar-26101+18%+30%1616%124.36
Dec-2586+18%+15%1214%103.62
Sep-2573+12%-3%1115%72.70
Jun-2565-17%+2%813%62.33
Mar-2578+4%1216%9
Dec-24750%1419%10

Concall takeaways (FY26)

• Water Technologies (~87% of revenue) grew ~5%, supported by a strong order book.
• Q4 water-treatment chemicals saw ~+10% volume YoY tracking sector recovery.
• Management guiding to scale construction chemicals and distribution.
• H2 markedly stronger than H1; Q4 revenue a nine-quarter high.

📊 TV Fundamentals Layout
IN Analytics + Fundamentals Panel — TradingView Desktop Capture
Captured from TradingView Desktop FUNDAMENTALS layout · Stage / RS / Momentum / Quarterly P&L / Defensive Screener / Scenarios · 16 Jun 2026
CHEMBONDCH Fundamentals Layout
Source: TradingView Desktop — FUNDAMENTALS layout · Research Reference Only
A10 · Valuations
Own history (consolidated)
MetricCurrentHistorical medianRead
P/E13.9x~12.1xSlight premium
P/B2.6x~2.3xNear median
EV/EBITDA8.5x~8.5xAt median

TradingView composite-value model reads ~13% downside to fair value (₹156.9 FV on PE-est); Graham fair value ~₹141.8. These are model outputs, not recommendations.

Peer comparison
CompanyMkt Cap ₹CrP/EROCE%ROE%Model
Chembond Chemicals48413.92418Chemicals + service
VA Tech Wabag10,93232.42417.4Water EPC + O&M
Ion Exchange (India)5,35736.113.411.2Resins + EPC + chemicals
Praj Industries~13,000~35~25~20Bioenergy + water (adjacent)

Chembond trades at a steep P/E discount to listed water peers, but it is a smaller, product-led supplier (not an EPC/O&M player) with weaker cash conversion — so part of the discount is structural. Praj figures are approximate. Source: Screener.in / public data — research framing only.

A11 · Orders Tracking

Chembond does not disclose a granular order-book number in aggregator data; management describes the water-vertical order book as “strong” and credits it for ~5% water-segment growth in FY26. The chemicals portion of revenue is recurring-consumption rather than discrete order-book, so book-to-bill is less central than for EPC peers.

MetricReadSignal
Water order bookDescribed “strong”, supporting ~5% segment growthMonitor
Revenue visibilityRecurring chemicals base + equipment/tender winsResilient
Q4 momentumNine-quarter high revenue; +10% chemical volume YoYImproving

Quantified order-intake disclosure is not available in aggregator feeds — track concall and the FY26 annual report for water-BU order-book figures (the FY filing references “New Order Book — Water Business Unit” line items).

A12 · Track Record + Walk vs Talk

Management is a long-standing promoter group (business since 1974). Post-demerger the standalone track record as a pure-play is short (essentially FY26 as the first full year), which limits guidance-accuracy scoring. Available signals:

Claim / themeFY26 outcomeRead
Water-sector recovery to drive volumesQ4 chemical volume +~10% YoY; H2 >> H1✅ Delivered
Margin discipline ~15% OPMFY26 OPM ~15%; held through the year✅ Delivered
Grow construction chemicals / distributionStated priority; scale not yet evident in mix⚠ In progress
Cash conversionCFO ₹8 Cr vs PAT ₹35 Cr; WC days rose🔴 Lagging

Red-flag checklist

✅ No guidance cuts evident   ✅ No unexplained CFO/CEO change   ✅ No promoter pledge   ⚠ Working capital growing faster than revenue — watch related-party and receivable quality in the annual report.

A13 · Issues + Risks
HIGH

Cash conversion

CFO well below PAT (~0.23x) with WC days rising to 154. Reported profit is not fully translating to cash.

Mitigant: debt-free, so WC is self-funded; watch for normalisation in FY27.

HIGH

Receivable build-up

Debtor days 99→128 over two years — concentration in slow-paying industrial/PSU clients risks write-downs.

Mitigant: diversified industrial base; no single-name disclosure of stress.

MEDIUM

Scale disadvantage

Sub-₹500 Cr cap competing with ₹5,000–11,000 Cr Wabag/Ion Exchange; limited bargaining and bid scale.

Mitigant: niche chemicals/service focus, not head-to-head EPC.

MEDIUM

Input-cost volatility

Crude-derivative feedstock swings can compress gross margin; pass-through lags.

Mitigant: OPM held ~15% through FY26.

MEDIUM

Thin float & liquidity

Free float ~35%, low traded volumes (RVOL <1); price can be volatile and hard to exit.

Mitigant: promoter ~65% gives alignment.

MEDIUM

Short standalone history

Demerger completed Apr 2025 — limited multi-year track record as the re-shaped entity; estimates rest on a thin base.

Mitigant: 50-year operating legacy of the group.

LOW

Valuation re-rating risk

Trades at a discount to peers; if growth disappoints the discount could persist or widen.

Mitigant: low absolute P/E vs peers cushions downside somewhat.

A14 · Key Milestones to Track

Research tracking milestones — not investment signals

MilestoneWatch forTimelineWhy it matters
FY26 annual reportSegmental split, water order book, receivable ageingBy Aug 2026Validates mix & quality of growth
Q1 FY27 resultsRevenue >₹75 Cr & CFO catch-up~14 Aug 2026Tests whether H2FY26 momentum sustains
Working-capital normalisationWC days back below ~120FY27Key to cash-conversion repair
Construction-chemicals scale-upVisible revenue contribution in mixFY27–28Diversification beyond water
Promoter lock-in expiryAny supply event post Jan 2027Jan 2027Potential float/overhang change
A15 · Ownership

Detailed quarter-by-quarter shareholding was not retrievable from the data feed (login-gated). From the TradingView corporate panel the free float is ~35%, implying promoter holding of roughly ~65%, with a post-relisting promoter lock-in running to ~Jan 2027. No promoter pledge is flagged.

HolderApprox. stakeNote
Promoter group~65%Lock-in to ~Jan 2027; aligned, no pledge flagged
Public / float~35%Thin float, low daily volumes

Verify exact FII/DII split in the latest BSE shareholding filing — institutional ownership is likely small given the size and recent relisting.

A16 · Scenario Analysis

Scenario analysis — for research reference only. Not an investment recommendation.

Primary metric: P/E (profitable, asset-light product business). Scenarios anchor to FY27 earnings power and a multiple range from own history (trough), peer median, and an upper re-rating case. Values below mirror the TradingView scenario engine (1Y) and are illustrative.

🔴 Bear — ~24% weight

WC stress + growth stall, sector de-rating.
1Y ~₹113 (−37%)
2Y ~₹94 · 3Y ~₹78

🟡 Base — ~40% weight

Mid-teens growth, OPM ~15%, multiple steady.
1Y ~₹190 (+6%)
2Y ~₹204 · 3Y ~₹218

🟢 Bull — ~36% weight

Construction-chem ramp + cash-conversion repair + re-rating toward peers.
1Y ~₹289 (+61%)
2Y ~₹379 · 3Y ~₹497

Expected value (probability-weighted, TradingView model): ~₹208 (1Y). Triggers: Bear — two consecutive weak quarters / WC days >160; Base — guidance delivered ±10%; Bull — CFO/PAT >0.6 + construction-chem scale + re-rating. These are research scenarios, not price targets.

📈 Live Chart — Point VCP / Dark Mode Layout
Captured from TradingView Desktop · NSE:CHEMBONDCH · Daily · 16 Jun 2026 — all levels are research reference levels, not signals.
CHEMBONDCH point VCP dark-mode chart
Source: TradingView Desktop — point vcp layout · Research Reference Only
B0 · Stage Analysis + Setup
Weekly TA: BUY Daily TA: Neutral Stage 2 (Advancing) / S3→S1 transition Setup: Pullback to fast MA RS vs Midsmall400: Outperforming HH/HL structure: Unconfirmed Volume: Dry-up

The point-VCP panel reads a BUY with the stock in an early Stage-2 advance after a prolonged Stage-3/4 base (the Aug-2025 launch → multi-month base → spring → recovery is visible on the chart). Current setup is a pullback into the fast moving average with volume drying up — constructive, but the higher-high/higher-low structure is still “unconfirmed” and there is no volume breakout yet.

B1 · Momentum + Volume + Price Action
IndicatorReadingZone
Weekly TA consensusBuy (score 0.42; MA 0.75, osc 0.09)Constructive
Daily TA consensusNeutral (0)Balanced
Moving-average alignment (W)Strongly bullish (MA score 0.75)Bullish
MomentumRecovering; TD Seq buy setup 9Turning up
VolumeDry-up on pullback; no breakout volume yetWatch
EMA distance (F/M/S)-1.9% / -5.2% / -8.8% (price above slow EMA)Healthy cushion

52-week range: ₹104.85 (low) — CMP ₹180 — ₹245 (high). Price sits in the upper-middle of the range, ~26% below the 52W high. Note: outperforming the Midsmall400 but mildly lagging the broad CNX500 (RS -3.16%).

B2 · Key Levels
₹158.8
Low/base
₹163
LC support
₹168.5
Setup stop
₹180
CMP
₹200
52W-pivot R1
₹208
Next resistance
₹227
R2

Research reference levels only. Supports: ₹168.5 / ₹163 / ₹158.8. Resistances: ₹200 / ₹208 / ₹227. 20-EMA(W) trail ~₹164. Fair-value model ~₹172.6.

B3 · Trend + Relative Strength
SymbolTV signalScore
CHEMBONDCHBuy0.21
VA Tech WabagBuy0.28
Praj IndustriesNeutral-0.09
Ion ExchangeSell-0.22

Among water peers, Chembond ranks second on combined daily+weekly TA — behind Wabag, ahead of Praj and Ion Exchange. It is outperforming the Midsmall400 but mildly lagging the CNX500; relative strength is improving off the base.

B4 · R:R — Research Reference Only

⚠️ For research reference only. These are not buy/sell recommendations.

Entry zone

₹180

Pullback-to-fast-MA reference

Reference stop

₹168.5

-6.5% · below setup low

Reference target 1

₹203

+12.9% · ~2R

Reference target 2

₹227 (+26%, ~4R)

Reference target 3

₹250 (+39%, ~6R)

R:R to stop

~1 : 2.4

B5 · Technical Milestones
EventLevelSignificance
Confirms advanceWeekly close > ₹208 on above-average volumeClears next resistance; confirms HH/HL
Invalidates setupWeekly close < ₹163 / 20-EMA(W) ₹164Breaks base support; trend reference fails
CatalystQ1 FY27 results ~14 Aug 2026Earnings-driven move; PEAD is strong (>10%)
⚡ CONSOLIDATED VIEW THESIS
Research Reference Only — Not an Investment Recommendation · Primaegis Research Pipeline
💡 INVESTMENT CASE SUMMARY

Chembond Chemicals is a re-focused, debt-free water-treatment specialty-chemicals supplier created by the April-2025 demerger, with the water vertical now ~87% of revenue. FY26 was its first full year as a pure-play and ended on strong momentum — a nine-quarter-high Q4 (revenue +30%, PAT +33% YoY) with ~15% margins and high capital efficiency (ROCE ~24%). It trades at a steep P/E discount (13.9x) to far larger water peers (Wabag 32x, Ion Exchange 36x), but the discount is partly structural — smaller scale, thin float, a short standalone record, and notably weak cash conversion (CFO ~₹8 Cr against PAT ~₹35 Cr) as working-capital days climb. The research case rests on whether the company can convert profit into cash and scale its second engine (construction chemicals) while the water tailwind persists.

📊 FUNDAMENTAL PILLARS
Debt-free, capital-efficient
Zero borrowings, ROCE ~24%, asset-light. Source: A5/A8
Structural water-reuse tailwind
ZLD/reuse mandates drive recurring chemical demand. Source: A3/A6
Cheap vs water peers
13.9x P/E vs 32–36x for Wabag/Ion Exchange. Source: A10
Improving momentum
Q4FY26 nine-quarter-high revenue, PAT +33% YoY. Source: A9
📉 TECHNICAL POSTURE
Early Stage-2 / pullback
Weekly BUY; HH/HL unconfirmed. Source: B0
MA-aligned, momentum turning
Weekly MA score 0.75; daily neutral; volume dry-up. Source: B1
Risk envelope
Support ₹163–168; resistance ₹200–208. Source: B2
RS improving
2nd among water peers; leads Midsmall400, lags CNX500. Source: B3
Fundamentals vs Technicals
MIXED — leaning constructive
Fundamentals are sound but cash-conversion proof is pending; technicals are constructive but unconfirmed — a setup to track for confirmation rather than one that is fully aligned today.
⚠️ PRIMARY RISKS TO THESIS
Cash conversion
If CFO/PAT stays <0.4 with WC days >160, earnings quality thesis breaks.
Receivable quality
Debtor days 128 and rising — write-downs would hit reported PAT.
Growth disappointment
If construction-chem doesn’t scale, the peer-discount persists.
🎯 RESEARCH WATCHLIST VERDICT
MONITOR
🔑 Catalyst: Q1 FY27 results (~14 Aug 2026) — revenue & CFO catch-up
⏱ Horizon: Medium-term (3–12M)
Research tracking priority only — not a buy/sell/hold recommendation per SEBI (RA) Regulations 2014.
Primaegis Research Opinion · Internal Analyst View
ACCUMULATE
📊 Conviction: Medium ⏱ Horizon: Medium-term (3–12M)
🔄 Would upgrade to BUY if CFO/PAT >0.6 and weekly close >₹208 on volume; downgrade to NEUTRAL if WC days >160 or Q1FY27 revenue <₹75 Cr.
STRONG BUY BUY ▸ ACCUMULATE NEUTRAL REDUCE SELL STRONG SELL
⚠️ This is an internal, unregulated analytical opinion of Primaegis Research for internal pipeline use only. It does NOT constitute a SEBI-regulated investment recommendation, research report, or solicitation to buy, sell, or hold any security. Consult a SEBI-registered investment advisor before making any financial decision.
⚠️ IMPORTANT DISCLAIMER
This document is a research and educational output only, generated by the Primaegis Research Investment Analysis Pipeline. Neither Ameya Pimpalgaonkar nor any contributor to this report is a SEBI registered investment advisor or research analyst. Nothing in this report constitutes investment advice, a research recommendation, or a solicitation to buy, sell, or hold any security, fund, or financial instrument under SEBI (Research Analyst) Regulations, 2014 or any other applicable law. All financial data is sourced from publicly available disclosures. All technical levels are reference levels for research tracking only. Always conduct your own due diligence and consult a SEBI registered investment advisor before making any financial decision.

Generated: 16 June 2026 | Primaegis Research · Not for distribution.